Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02017548 · ClinicalTrials.gov registry record · NA

Default Options in Advance Directives

A NA study, sponsored by University of Pennsylvania.

Completed
Registry status
NA
Development phase
270
Enrollment target

NCT02017548: Completed NA study, sponsored by University of Pennsylvania.

NCT02017548 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 270 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02017548, a NA study, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
NA
Development phase
270 participants
Enrollment target

Study Summary

In a multicenter, randomized clinical trial of default options in advance directives among patients with incurable diseases, we will determine whether this simple and readily scalable intervention can improve patients quality of life and reduce resource utilization without reducing the number of days that patients are alive and living outside of an acute-care hospital.

Interventions

  • BEHAVIORAL Life-extension default advance directive
  • BEHAVIORAL Comfort default advance directive

Trial Details

FieldValue
Enrollment Target 270 participants
Start Date 2014-01
Est. Completion 2016-11
Phase NA

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT02017548

The ClinicalTrials.gov registry entry for NCT02017548 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 270 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Life-extension default advance directive is the first listed.

NCT02017548 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02017548 about?

NCT02017548 is a clinical study titled "Default Options in Advance Directives". In a multicenter, randomized clinical trial of default options in advance directives among patients with incurable diseases, we will determine whether this simple and readily scalable intervention can improve patients quality of life and reduce resource utilization without reducing the number of day...

What is the current status of trial NCT02017548?

This trial is currently completed. It is a NA study. The enrollment target is 270 participants. The study started on 2014-01. Estimated completion is 2016-11.

What interventions are being tested in trial NCT02017548?

The interventions under investigation include: Life-extension default advance directive (BEHAVIORAL), Comfort default advance directive (BEHAVIORAL).

Who is sponsoring clinical trial NCT02017548?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.